FilingIndex
DEF 14AThe Ballot

REGENERON PHARMACEUTICALS, INC. files DEF 14A

Filed Apr 25, 2017 · 9y ago · Accession 0001104659-17-025609

Plain English

Proxy statement — executive pay, board nominees, and shareholder votes.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Ticker
REGN
CIK
872589
Form type
DEF 14A
Filing date
Apr 25, 2017
Report date
Jun 9, 2017
Document
a17-2327_1def14a.htm
Size
38.7 MB